Nanopharmaceutical and Regulatory Science (McNeil)Head of Research UnitOverviewMembersPublicationsProjects & CollaborationsProjects & Collaborations OverviewMembersPublicationsProjects & Collaborations Projects & Collaborations 3 foundShow per page10 10 20 50 In-vivo-Wirksamkeitsnachweis einer LNP-basierten Enzymersatztherapie bei Morbus Pompe Research Project | 1 Project MembersImported from Grants Tool 4725712 NanoZymeX: Increasing Enzyme Uptake to Normalize the Life Expectancy and Quality of Pompe Patients Research Project | 1 Project MembersNanoZymeX develops lipid nanoparticle–based enzyme replacement therapy for Pompe disease. By improving efficacy and eliminating immunological side effects, we aim to extend the life expectancy and improve the quality of life of Pompe disease patients. Investigating the Role of Alpha-Mannosidosis on Transcytosis in Brain Endothelial Cells Derived from Human Induced Pluripotent Stem Cells (hIPSCs) Research Project | 2 Project MembersImported from Grants Tool 4718685 1 1 OverviewMembersPublicationsProjects & Collaborations
Projects & Collaborations 3 foundShow per page10 10 20 50 In-vivo-Wirksamkeitsnachweis einer LNP-basierten Enzymersatztherapie bei Morbus Pompe Research Project | 1 Project MembersImported from Grants Tool 4725712 NanoZymeX: Increasing Enzyme Uptake to Normalize the Life Expectancy and Quality of Pompe Patients Research Project | 1 Project MembersNanoZymeX develops lipid nanoparticle–based enzyme replacement therapy for Pompe disease. By improving efficacy and eliminating immunological side effects, we aim to extend the life expectancy and improve the quality of life of Pompe disease patients. Investigating the Role of Alpha-Mannosidosis on Transcytosis in Brain Endothelial Cells Derived from Human Induced Pluripotent Stem Cells (hIPSCs) Research Project | 2 Project MembersImported from Grants Tool 4718685 1 1
In-vivo-Wirksamkeitsnachweis einer LNP-basierten Enzymersatztherapie bei Morbus Pompe Research Project | 1 Project MembersImported from Grants Tool 4725712
NanoZymeX: Increasing Enzyme Uptake to Normalize the Life Expectancy and Quality of Pompe Patients Research Project | 1 Project MembersNanoZymeX develops lipid nanoparticle–based enzyme replacement therapy for Pompe disease. By improving efficacy and eliminating immunological side effects, we aim to extend the life expectancy and improve the quality of life of Pompe disease patients.
Investigating the Role of Alpha-Mannosidosis on Transcytosis in Brain Endothelial Cells Derived from Human Induced Pluripotent Stem Cells (hIPSCs) Research Project | 2 Project MembersImported from Grants Tool 4718685
